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Abstract 
Development of versatile, chemically tunable photocages for photoactivated chemotherapy (PACT) 
represents an excellent opportunity to address the technical drawbacks of conventional photodynamic 
therapy (PDT) whose oxygen-dependent nature renders it inadequate in certain therapy contexts such as 
hypoxic tumors. As an alternative to PDT, oxygen free mechanisms to generate cytotoxic reactive oxygen 
species (ROS) by visible light cleavable photocages are in demand. Here, we report the detailed 
mechanisms by which the small molecule blebbistatin acts as a one-photon blue light-gated or two-
photon near-infrared light-gated photocage to directly release a hydroxyl radical (•OH) in the absence of 
oxygen. By using femtosecond transient absorption spectroscopy and chemoselective ROS fluorescent 
probes, we analyze the dynamics and fate of blebbistatin during photolysis under blue light. Water-
dependent photochemistry reveals a critical process of water-assisted protonation and excited state 
intramolecular proton transfer (ESIPT) that drives the formation of short-lived intermediates, which 
surprisingly culminates in the release of •OH but not superoxide or singlet oxygen from blebbistatin. 
CASPT2//CASSCF calculations confirm that hydrogen bonding between water and blebbistatin underpins 
this process. We further determine that blue light enables blebbistatin to induce mitochondria-dependent 
apoptosis, an attribute conducive to PACT development. Our work demonstrates blebbistatin as a 
controllable photocage for •OH generation and provides insight into the potential development of novel 
PACT agents. 
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nature renders it inadequate in certain therapy contexts such as hypoxic tumors. As an alternative to PDT, oxygen free mechanisms 
to generate cytotoxic reactive oxygen species (ROS) by visible light cleavable photocages are in demand. Here, we report the detailed 
mechanisms by which the small molecule blebbistatin acts as a one-photon blue light-gated or two-photon near infrared light-gated 
photocage to directly release a hydroxyl radical (•OH) in the absence of oxygen. By using femtosecond transient absorption 
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blue light. Water-dependent photochemistry reveals a critical process of water-assisted protonation and excited state intramolecular 
proton transfer (ESIPT) that drives the formation of short-lived intermediates, which surprisingly culminates in the release of •OH  
but not superoxide or singlet oxygen from blebbistatin. CASPT2//CASSCF calculations confirm that hydrogen bonding between 
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INTRODUCTION 
Photosensitizers have been a subject of intense study since 
the advent of photodynamic therapy (PDT) whose efficacy 
has been proven in multiple medical conditions, including 
viral infections and malignancies.1-3 The phototoxicity of PDT 
agents relies on catalytic conversion of molecular oxygen into 
primary reactive oxygen species (ROS), particularly 
superoxide or singlet oxygen.4 Of particular import, hydroxyl 
radical (•OH) is a common executor of cytotoxicity or 
antimicrobial activity of photosensitizers in oxygen-
dependent photochemistry. In solid tumors or under hypoxic 
conditions, however, low levels of oxygenation present a 
fundamental challenge to PDT applications due to the intrinsic 
requirement of dioxygen for ROS generation. In addition, 
PDT itself is known to induce acute hypoxia due to the 
depletion of oxygen in local tissues, blunting PDT efficacy.5 
Thus, it is imperative to develop an oxygen-free strategy to 
generate ROS by photoswitchable agents for eliminating 
microbial pathogens or cancer cells under hypoxia. In contrast 
to PDT, photoactivated chemotherapy (PACT) utilizes 
prodrugs shielded by a photocleavable protecting group, 
which become bioactive following light-triggered 
deprotection. In recent years, the development of novel PACT 
agents have focused on d-block metal-based complexes 
capable of releasing cytotoxic species against cancer cells.6 
While many PACT agents are commonly photoexcitable 
under UV to generate ROS, photoswitching at visible light is 
desirable for therapeutic development.7-10 
In designing novel PACT agents, organic small molecules 
are potentially advantageous in that they are highly amenable 
to chemical modifications to afford useful attributes such as 
aqueous solubility, subcellular targeting, and longer 
wavelengths for photoexcitation. Here, we report that 
blebbistatin is a blue light or two-photon near infrared light-
cleavable photocage and releases •OH in an oxygen-
independent manner through a unique photochemical 
mechanism. 
()-Blebbistatin, a small molecule first identified as a 
highly selective, potent reversible non-muscle myosin II 
ATPase inhibitor, has been recognized for its utility in 
studying the temporal and spatial control of cytokinesis.11-14 
Since its discovery, blebbistatin has had a notable impact on 
research in biomedicine by virtue of its extensive utilization 
in the mechanistic scrutiny of diverse phenomena including 
cell migration,11,13,15 axon guidance,16 stem cell self-renewal17 
and cell cycle control.18 Intriguingly, blebbistatin becomes 
rapidly inactivated upon light irradiation and exhibits 
phototoxicity in living cells.19-21 It was speculated that such 
photoinactivation (λex=450-490 nm) and phototoxicity of 
blebbistatin arose from induction of ROS whose identity 
remain unsubstantiated. Mikulich et al. confirmed that UV or 
blue light (390-470 nm, peak at 420 nm) was sufficient for 
rapidly sensitizing cancer cells to cell death.21 They further 
posited that certain ROS other than singlet oxygen were 
plausibly involved. Intuitively, the lack of toxicity from 
photoreaction products favors the conjecture that irradiation 
produces a destructive transient by-product or intermediate 
species, or a very reactive moiety on blebbistatin itself. 
Although a variety of investigations have attempted to 
demystify the phototoxic effects from blebbistatin 
photoinactivation, there is a dearth of mechanistic 
understanding about the identity and characteristics of the 
critical intermediate(s) or photoproducts formed by 
blebbistatin under UV or blue light irradiation.19-24  
Given the intrinsic properties of blebbistatin, we envision 
that the presence of a hydroxyl group and carbonyl group 
probably allows blebbistatin to undergo excited state 
intramolecular proton transfer (ESIPT) with the assistance of 
a water bridge since water and hydrogen bonds are ubiquitous 
in chemistry and biology. Photoinduced ESIPT is a well-
known photochemical process, which often occurs across a 
hydrogen bond.25,26 ESIPT processes produce a tautomer with 
an electronic structure distinct from the original excited state, 
allowing larger Stokes shifts.27 In this work, a combined 
approach of femtosecond transient absorption (fs-TA) 
spectroscopy, computational analysis on potential energy 
profiles of the excited state, computational prediction of the 
absorption spectra of candidate intermediates, and 
photoproduct studies by resonance Raman, UV/Vis and 1H 
NMR spectroscopy was employed to verify the mechanisms 
underlying blebbistatin photoinactivation. Fluorometric 
experiments with several chemoselective ROS sensors further 
revealed that hydroxyl radical (•OH) appeared to be noticeably 
generated during photolysis of blebbistatin by blue light. •OH 
is highly active in inorganic synthesis,28 polymerization,29 and 
biomacromolecule modifications.30 Generation of •OH in 
solution can be achieved by means of electron pulse radiolysis, 
Fenton reaction, tetrachloro-1,4-benzoquinone (TCBQ) 
degradation and high-voltage electrical discharge.30-32 
Conceptually, the unprecedented one-photon blue light-
triggered or two-photon near infrared-triggered release of •OH 
from blebbistatin observed in this study can have several 
advantages over traditional methods. Especially, the two-
photon absorption of blebbistatin in the near infrared range 
makes it as an excellent potential anti-cancer agent. It also 
provides a useful template for the rational design of future 
PACT agents and chemical tools such as photocages for 
controlled delivery of •OH in living cells and tissues within an 
optically attractive therapeutic window. In cell experiments, 
blue light irradiation rapidly depolarized blebbistatin-treated 
cells, altered mitochondrial morphology, elevated 
mitochondrial superoxide production and activated caspase-
related apoptotic pathways. Photoinactivation of blebbistatin 
therefore enabled an underappreciated oxidative mode of 
cytotoxic action, possibly contingent on the generation of •OH 
under blue light. Collectively, we envision that blebbistatin 
can be further explored as a potential PACT agent with blue 
light and/or intense near infrared light for treating 
pathological conditions including skin infections and cancer, 
and its photochemical mechanisms revealed herein can 
provide valuable insight for the design and development of 
future photocaged compounds applicable to the precise and 
visible light and/or near infrared light-gated release of •OH in 
therapeutic contexts.   
Experimental and Computational Methods 
Sample preparation. ()-Blebbistatin, dihydrorhodamine 
123, hydroxyphenyl fluorescein solution (5 mM) in DMF and 
xanthine (X) / xanthine oxidase (XO) were acquired from 
commercial sources (Sigma-Aldrich) and were utilized 
without any additional treatment. The procedure of synthesis 
of HKSOX-1 is as described previously.33 The procedure of 
synthesis of HKOH-1 is as described previously.34 Thiourea, 
Fe2Cl, H2O2, spectroscopic grade acetonitrile (MeCN), DMF, 
potassium phosphate buffer (0.1 M, pH 7.4), D2O and 
deionized water were utilized to make up the samples 
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employed in the time-resolved spectroscopic measurements.  
A. Femtosecond transient absorption (fs-TA) 
experiments. The fs-TA measurements were performed with 
an apparatus and methods detailed previously35,36 and details 
are given in references 45 and 46. Very briefly, fs-TA spectra 
were obtained by employing the harmonic (400 nm light) for 
the pump pulse and white-light continuum (350800 nm light) 
for the probe pulse generated from the 800 nm output of a 
femtosecond regenerative amplified Ti:sapphire laser system 
For the measurements here, a solution of 40 mL was passed 
through a 2 mm thick cell, excited by a 400 nm pump pulse 
and then interrogated by the white light continuum pulse.    
B. Resonance Raman (RR) experiments. The RR 
experiments were done by employing a Nd:YAG laser which 
supplied the light source at 266 nm that excited a moving 
sample of ∼5 × 10−4 M concentration. The RR light was 
acquired and detected by a charge-coupled device (CCD). The 
RR spectra given here were determined via subtraction of a 
solvent without sample spectrum from a corresponding RR 
spectrum of solvent with sample primarily to remove solvent 
bands.35  
C. Fluorometric analysis of ROS. All fluorescence 
experiments were acquired at ambient temperature with a 
Hitachi F-7000 fluorescence apparatus. The DHR 123, 
HKSOX-1, HPF and HKOH-1 probe testing solutions were 
photoexcited at 500, 509, 490 and 500 nm, respectively. The 
probes were dissolved in DMF to make a 10 mM stock 
solution that solvent was added to obtain the required 
concentration of testing solutions for measurement. For DHR 
123, HKSOX-1, HPF probe, a LED lamp (30 W) with λex = 
410420 nm was employed to photoexcite the blebbistatin 
solutions. The fluorescence intensities of the testing solutions 
were recorded after 30 min. For HKOH-1 probe, a LED lamp 
(30 W) with λex = 480 nm was employed to photoexcite the 
blebbistatin solutions.  
D. Two-photon absorption cross-section measurements. 
Nonlinear optical properties were characterized by an 
open/close-aperture femtosecond Z-scan technique. The 
excitation source is a Ti:sapphire oscillator-seeded 
regenerative amplifier (Coherent, Astrella-Tunable-F-1k), 
which gives an output with a pulse energy of 7 mJ at 800 nm 
and a repetition rate of 1 kHz. The excitation intensity was 
adjusted by a set of natural filters with different transmittances. 
The laser beam was focused onto the sample with a beam 
waist of ~15 μm. Solution samples with known concentration 
were prepared in a quartz cuvette with 1 mm optical path 
length. The transmittance of the sample was measured as a 
function of input intensity, which was varied by moving the 
samples in and out of beam focus along the z-axis. The 
aperture before the detector was adjusted to be fully open for 
the open aperture Z-scan measurement and 30 % 
transmittance of the initial beam for the closed aperture Z-
scan measurement. At least 3 cycles were repeated to 
minimize experimental errors and the average values were 
calculated to plot out the Z-scan curves. 
D.  CASPT2//CASSCF calculations. To simulate the 
water-assisted ESIPT reaction of blebbistatin, a complex with 
five water molecules and a hydronium ion, i.e., 
blebbistatin·5H2O·H3O
+ was employed to account for the 
proton transfers from the donors (O5 and W6) and acceptors 
(O3 and N1). Many test calculations were done by utilizing 
B3LYP/6-31G* to find the structure of the 
blebbistatin·5H2O·H3O
+ complex in which the hydrogen 
bonds could maintain in the range of 1.50~1.80 Å. The same 
computational strategy has been repeatedly verified, which 
successfully describes the ESIPT reaction over a long distance 
in our previous studies.37,38 Ab initio computations were done 
employing the complete active space self-consistent field 
(CASSCF) method with a 6-31G* basis set and that made use 
of a total of 12 electrons in 11 active space orbitals (12e/11o). 
The higher energy occupied π, lower energy π* orbitals, the n 
orbitals and the related σ/σ* orbitals are contained in the 
active space. All of the critical points in the reaction pathways 
were obtained by CASSCF optimizations in which a state-
averaged approach with two-roots equally weighted (0.5:0.5) 
was used for the singlet excited states, while the triplet and 
ground states made use of a single root optimization. 
Consideration of the effects of dynamic electron correlation 
was done by finding the single-point energy of the optimized 
geometries that were recalculated utilizing the second-order 
perturbation method (CASPT2) with a five-root state-
averaged CASSCF zeroth-order wave function. All of the 
preceding computations were done making use of Gaussian39 
and Molcas program packages.40 
E. Cell culture and cytotoxicity assay. Mouse B-16 
melanoma cells and human A-375 melanoma cells were 
acquired from the Cell Bank of Type Culture Collection of 
Chinese Academy of Sciences, Shanghai, China and kept in 
RPMI-1640 medium (Gibco) supplemented with 10% FBS 
and 1% penicillin/streptomycin for mouse B-16 melanoma 
cells and DMEM (high glucose; Gibco) supplemented with 10% 
FBS and 1% penicillin/streptomycin for human A-375 
melanoma cells. For assessing cytotoxicity of blue light 
illuminated blebbistatin, cells were allowed to grow to 70-80% 
confluence, and plated into 96-well microplates (Corning) at 
a density of 8×104 cells/mL, followed by recovery at 37°C and 
5% CO2 for 1618 h. Blebbistatin was dissolved in DMF then 
added to a culture medium to obtain a range of concentrations 
(0200 µM), in replicates of 5. Typically, the cells were then 
placed under a blue LED lamp (λex = 410420 nm; 30 W, ca. 
23.8 mW/cm2) with a distance of 10 cm then irradiated 30 min. 
In a control plate added with the same range of blebbistatin 
doses, the cells were left to stand for 30 min without light 
exposure. In experiments involving •OH scavenging, thiourea 
of various concentrations (050 mM) was put on the cells 
prior to blue light illumination and then the cells were 
incubated for another 24 h. At completion of the experiment, 
20 µL MTT solution (5 mg/mL) was put into each well and 
subsequently incubated for 4 h. The cells were then washed 
and incubated with 150 µL DMSO per well. The samples were 
gently rocked on an orbital shaker (10-15 min) and then the 
450 nm absorbance was measured. Data were analyzed with 
Microsoft Excel and GraphPad Prism. 
F. Live cell confocal fluorescence microscopy. The 
commercial fluorescent dyes/probes MitoSOX, JC-1, 
MitoTracker Deep Red used in this study were obtained from 
Life Technologies, and propidium iodide (PI) was from Sigma. 
The green-emission superoxide probe HKSOX-133 was a gift 
from Prof. Dan Yang. Melanoma cells (5×104 cells/mL) were 
plated into 3.5-cm confocal dishes one day before imaging 
experiments. Prior to blue light illumination, the cells were 
loaded with fluorescent probes for mitochondrial superoxide 
MitoSOX (2 µM) or mitochondrial membrane potential probe 
JC-1 (2.5 µM), or the organelle-specific dye for mitochondria 
MitoTracker Deep Red (20 nM) for 30 min. Then the cells 
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were washed with HBSS to terminate staining, and were then 
challenged with blebbistatin in the presence or absence of blue 
light (30 min or otherwise specified) in culture medium. PI (1 
µg/mL) was added immediately before blue light illumination 
of blebbistatin. Images were obtained with a confocal 
fluorescence microscope (Zeiss LSM 700). Fluorescence 
quantification was done with ImageJ. 
G. Flow cytometry (FACS) analysis of cell death. 
Melanoma cells were allowed to grow to 70-80% confluence 
and then plated into 6-well plates (Corning) at a density of 
5×104 cells/mL. After overnight recovery, the cells were 
subjected to blebbistatin (25 µM) with or without blue light 
present for 30 min. After blue light illumination, the cells 
underwent an additional 4 h of incubation. The cells were then 
digested briefly with trypsin, followed by neutralization by 
fresh serum (30 s). On determining cell density, cells 
underwent centrifugation (1200 rpm for 5 min). The 
supernatant was disposed of and then about 0.5-1×105 cells 
were pelleted in a 5-mL falcon tube. The cells were 
resuspended by adding 195 µL of Annexin V-FITC binding 
buffer. To each sample, 3 µL of the Annexin V-FITC staining 
solution (Beyotime Biotechnology) was added, followed by 
gentle rocking. The cells were shielded from light then 
underwent incubation on ice for 10 min, and resuspended a 
few times to improve staining. Before loading to assess cell 
death on a flow cytometer (BD FACSCanto II), the cells were 
stained very briefly with PI (1 µg/mL; Sigma). For each 
sample, at least 104 cell events were included for analysis. 
FACS data were analyzed with FlowJo software.  
H. Caspase activity assays. Melanoma cells were allowed 
to grow to 70-80% confluence in T75 flasks (Corning) and re-
plated in T25 flasks before treatment. Following overnight 
recovery, the cells were given blebbistatin (25 µM) with or 
without blue light for 30 min. The cells were washed in PBS, 
detached by trypsinization and harvested by centrifugation 
(600× g, at 4°C for 5 min). To about 2×106 cells of each group, 
100 µL of RIPA lysis buffer was added to resuspend and lyse 
the cells on ice (15 min). The samples was subjected to 
centrifugation at 12000 rpm (Eppendorf Centrifuge 5424 R), 
4°C for 15 min. The supernatants were acquired then assayed 
for the concentration of protein by BCA method. Caspase 3 
and caspase 8 activities were determined by using 
colorimetric caspase activity assay kits (Beyotime 
Biotechnology) for these enzymes with the help of a standard 
curve for the caspase cleavage product pNA (p-nitroaniline). 
RESULTS AND DISCUSSION 
1. Femtosecond transient absorption studies on the early 
events of photophysics and photochemistry of blebbistatin 
So as to elucidate the early events of blebbistatin 
photoinactivation, ultrafast laser flash photolysis was 
employed to record the transient absorption of the excited 
states and intermediates of blebbistatin in a 1:1 MeCN:H2O 
solution (Figure 1). Several processes were at work after 
initial excitation up to 400 ps. During the first several hundred 
femtoseconds, the initial excitation of the molecule gave rise 
to a singlet excited state, which then quickly evolved into the 
S1 excited state with a prominent band around 475 nm. From 
1.1 ps to 1.3 ps, the growth of an intermediate with a 
noticeable band at 650 nm was observed along with 
intensification of a conspicuous absorption at 475 nm (Figure 
1a). This can be attributed to a very fast protonation of the  
 
Figure 1 Shown here are the fs-TA spectra of species produced in a MeCN:H2O 1:1 solution acquired after 400 nm excitation of blebbistatin 
from 1.1 ps to 1.3 ps (a), from 1.3 ps to 5.0 ps (b), and from 6.5 ps to 400 ps (c). d, Comparison between the transient absorption at 6.5 ps 
(orange) and TD-DFT calculated absorption (dark cyan) of intermediate 2 (see Figure 2 for structure). e, Kinetics of the characteristic 
absorption band observed at 475 nm in the fs-TA spectra after 400 nm excitation of blebbistatin in MeCN:H2O 1:1 (squares) and MeCN:D2O 
1:1 (circles) solutions. f, The kinetics of the characteristic absorption band observed at 475 nm for the fs-TA spectra after 400 nm excitation 
of blebbistatin in MeCN (triangles), MeCN:H2O 1:1 (circles) and MeCN:H2O 1:9 (squares) solutions. The solid lines indicate the fittings to 
the data by using a singlet exponential function. 
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nitrogen atom to produce intermediate 1 (Figure 2a). 
Intermediate 1 then underwent an ESIPT with the aid of water 
bridges to produce intermediate 2 (Figure 2a) that had a 
characteristic band at 550 nm along with the intense 
absorption at 475 nm (Figure 1b). Figure 1d shows that the 
experimental transient absorption bands at 6.5 ps agree nicely 
with the TD-DFT calculated spectrum of the absorption of the 
singlet excited state of intermediate 2. Finally, the transient 
having a maximum absorption at 475 nm and weak nearby 
absorption at 550 nm evolved into a short-lived epoxide-like 
transient 3 (Figure 2a) in which the C=O double bond 
chromophore disappeared such that the epoxide-like transient 
absorption bands changed to the UV region (calculations 
predicted at 237 nm and 316 nm) beyond the detection range 
of our fs-TA spectrometer (350-800 nm). Electron transfer 
leads to ring-opening of the epoxide-like transient and 
formation of intermediate 4, which subsequently underwent 
electron transfer to generate the final product with the 
concomitant release of •OH (Figure 2a). Because the 
photolysis of blebbistatin has been conducted in aqueous 
solutions, the source of the electron may mainly come from 
the solvent water molecules. That is to say, the water 
molecules may be oxidized to serve an electron donor. In 
addition, we postulated two alternative photochemical 
mechanisms. The first involves initial protonation of N atom 
and subsequent aromaticity as a driving force for •OH 
formation (Figure 1S). The second involves intramolecular 
electron transfer taking place first at the excited state and 
subsequent aromaticity as a driving force for •OH formation 
(Figure 2S). However, the calculated absorption of the key 
intermediates involved in these two mechanisms did not 
match with the experimental femtosecond transient 
absorption. Recently, Malnasi-Csizmadia and coworkers 
designed a blebbistatin derivative with an electron 
withdrawing group (nitro) substituted at C15, the photo- and  
 
 
Figure 2 Proposed photochemical mechanism for blebbistatin 
photoinactivation is shown (a). Shown are the absorption 
spectrum of the final product of blebbistatin after 416 nm 
excitation in a MeCN:H2O 1:1 solution (top) and a TD-DFT/6-
311G(d,p) predicted absorption spectrum of the final product 1 
(bottom) (b). The experimental resonance Raman spectrum (top) 
of the final product of blebbistatin observed after 416 nm 
excitation and a comparison to the calculated normal Raman 
spectrum (bottom) of the final product 1 (c). 
cytotoxicity, photosensitivity and fluorescence of blebbistatin 
were ablated without changing its enzyme inhibitory 
activity.22 This evidence strongly suggests that the lone-pair 
electrons of nitrogen in pyrrolidine are significantly 
delocalized in the benzene ring due to the para-nitro group. 
Therefore, the back electron transfer channel is expected to be 
weak, which hampers the cleavage of CO bond to produce a 
very reactive •OH intermediate in the case of para-
nitroblebbistatin. The exploration of the photophysical and 
photochemical reaction mechanisms is to be discussed further 
in conjunction with results from CASPT2//CASSCF 
calculations (described below). 
2. Formation of •OH and final product during blebbistatin 
photoinactivation 
In our study, the final photoinactivated product was examined 
with Raman and UV-vis absorption and NMR spectroscopies. 
The good agreement of our NMR spectrum of the final 
product with the literature reported NMR spectrum24 supports 
the notion that overall, blebbistatin appears to lose an oxygen 
atom to form the final product after blue light excitation 
(Figure 2a). This view is also supported by a significant match 
between the calculated absorption and Raman spectra of final 
product 1 with the experimental UV-vis absorption and 
resonance Raman spectra of photoproducts (Figure 2b and 2c). 
Figure 1e presents the kinetics of the diagnostic 475 nm 
absorption after 400 nm excitation of blebbistatin in 
MeCN:H2O 1:1 and MeCN:D2O 1:1 solutions. The decay time 
constants were found to be 78 ps and 107 ps in 
MeCN:H2O=1:1 and MeCN:D2O=1:1 solutions, respectively. 
This isotope-dependent effect demonstrates that water 
molecules are involved during an ESIPT process that 
protonates the center ring N atom, which leads to the likely 
formation of a short-lived epoxide-like intermediate (Figure 
2a). We used piperidine, which is highly chemoselective to 
epoxides,41 to test this but no addition of amine to an epoxide 
compound was observed in water (data not shown). The 
results suggest that the epoxide-like intermediate produced 
after water-assisted ESIPT during blebbistatin 
photoinactivation must be a very short-lived species. 
Therefore, it appears that a process of ultrafast ring opening 
of the epoxide-like intermediate is at work to give the 
subsequent species 4 (Figure 2a) to account for its not being 
trapped by piperidine. To further clarify how water solvent 
participates in the ESIPT process, the kinetics of transient 
absorption at 475 nm has been examined after 400 nm 
excitation of blebbistatin in varying amounts of water aqueous 
solutions (Figure 1f). The decay time constants of 475 nm are 
164 ps (in MeCN), 78 ps (in MeCN:H2O=1:1) and 50 ps (in 
MeCN:H2O=1:9) solutions. This further confirms that water 
molecules participate in the ESIPT process and postulated 
formation of the epoxide-like intermediate. In addition, the 
formation of the final product 1 also appeared to require water 
molecules since the UV-vis absorption of blebbistatin did not 
change after illumination in MeCN solvent whereas there was 
clear conversion to final product 1 under similar illumination 
conditions in aqueous solutions (Figure 3S). In other words, 
the photochemical reactions of interest seemed to exclusively 
take place with the aid of water molecules. Here, an ESIPT 
process can possibly be driven by an increase in the 
aromaticity of the final product of blebbistatin.42-44 
3. Detection of ROS formation during blebbistatin 
photoinactivation by fluorescence measurement 
In a previous biological study by Kolega, the photoproducts 
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Figure 3 The fluorescence experiments were measured in the presence or absence of scavengers in potassium phosphate buffer (0.1 M, pH 
7.4, 0.1% DMF). a, Superoxide-dependent fluorescence response (λex = 509 nm) of HKSOX-1 (10 µM) following incubation with a xanthine 
(X) / xanthine oxidase (XO) donor system and blue light illuminated blebbistatin (10 µM) for 30 min. b, •OH dependent fluorescence 
response (λex = 490 nm) of HPF (10 µM) following incubation with blue light illuminated blebbistatin (10 µM) under normal aerobic 
conditions for 30 min. c, HPF (10 µM) fluorescence response following incubation with blue light illuminated blebbistatin (10 µM) for 30 
min with or without Ar purging (30 min). d, HPF (10 µM) fluorescence response (λex = 490 nm) following incubation with blue 
light illuminated blebbistatin (10 µM) and different concentrations of thiourea (•OH scavenger; 0, 0.1, 0.25, 0.5, 1 mM). e, HPF (10 µM) 
fluorescence response (λex = 490 nm) following reaction with blue light illuminated blebbistatin (10 µM) for 30 min or with Fenton’s reagent 
(10 µM Fe2+, 100 µM H2O2) for 30 min. f, Hydroxyl radical dependent fluorescence response (λex = 500 nm) of the •OH-selective fluorescent 
probe HKOH-1 (5 µM) following incubation with blebbistatin (5, 25 and 50 µM) under specified conditions for 20 min in the presence or 
absence of a •OH scavenger (2 mM thiourea) in potassium phosphate buffer (0.1 M, pH 7.4 0.1% DMF). Photoexcitation of blebbistatin was 
conducted at 480 nm. HKOH-1 (5 µM) also reacted with Fenton’s reagent (2 µM) as a technical control. 
generated by exhaustive 365 nm or 450-490 nm irradiation of 
blebbistatin were found to be nontoxic to cells, even for 
conditions of 50 µM and exhaustive exposure for 18 h.19 
These photoproducts and their reactive intermediates during 
photoinactivation of blebbistatin have since remained 
unidentified, with the latter being a more probable source of 
phototoxicity. According to the current fs-TA and final 
product analysis, the short-lived transients or ROS are more 
probable intermediates that can induce the observed cell death. 
Experiments done under argon-purged conditions reveal that 
involvement of singlet oxygen (1O2) can be ruled out because 
oxygen had been reduced to an extremely low level in the 
purged solution.45,46 Similarly, peroxynitrite can also be 
excluded as a possible reactive intermediate as there was no 
loss of nitrogen from blebbistatin. The only plausible ROS 
that can theoretically be formed are •OH and superoxide upon 
photoexcitation of blebbistatin. To validate this, several 
fluorescent probes were used to detect candidate ROS. 
Dihydrorhodamine 123 (DHR123) is a fluorescent indicator 
for hydrogen peroxide, peroxynitrite, superoxide and •OH.47,48 
Blue light illuminated  blebbistatin solution readily elicited 
a strong fluorescence enhancement of the nonselective ROS 
probe DHR123 (Figure 4S), while the same reaction 
conditions did not trigger fluorescence enhancement of the 
superoxide-selective probe HKSOX-1 (Figure 3a).33 
Therefore, superoxide seems an unlikely intermediate 
generated via blebbistatin photoinactivation. The well-
established •OH indicator hydroxyphenyl fluorescein  (HPF) 
is nonfluorescent in its pristine form and fluoresce strongly 
upon reaction with •OH or peroxynitrite.48-50 Figure 3b shows 
that the fluorescence of HPF was greatly enhanced following 
incubation with blue light illuminated blebbistatin (30 min). 
Fluorescence enhancement of HPF occurred equally 
efficiently under Ar purged and non-Ar purged conditions, 
suggesting that singlet oxygen as an intermediate involved is 
improbable (Figure 3c). To further verify if •OH is the 
candidate ROS species responsible for the phototoxicity of 
blue light illuminated blebbistain, thiourea was used as a 
selective scavenger to quench •OH reactions.51,52 Indeed, 
fluorescence measurement with HPF suggests a negative 
linear relationship between fluorescence intensity of HPF (10 
µM) and thiourea concentration (0-1 mM) (Figure 3d). Next, 
HKOH-1 as a very selective and sensitive fluorescent probe 
for detection of •OH34 was also used to further confirm the 
generation of •OH after irradiation of blebbistatin with blue 
light at 480 nm for 20 min. The fluorescence of HKOH-1 was 
significantly enhanced upon photoexcitation of blebbistatin, 
while this fluorescence enhancement was readily attenuated 
in the presence of 2 mM thiourea (Figure 3f). Based on the 
above evidence, it appears that •OH but not singlet oxygen or 
superoxide is generated during blebbistatin photoexcitation 
with blue light. This surprising observation is nonetheless 
consistent with our analysis on the final photoproducts that an 
oxygen atom was lost from the initial blebbistatin molecule 
(Figures 2b and 2c; Figure 5S and Figure 6S). Recently, 
Verhasselt and coworkers postulated that the photosensitizing 
a
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properties might be sufficient to generate hydroxyl or peroxyl 
radicals as water degradation products in an DMSO:water 
mixture upon blue light irradiation,53 though this has not been 
tested or proven experimentally. Very importantly, DMSO is 
considered inappropriate for studying blebbistatin 
photoinactivation as it is a well-documented potent scavenger 
for •OH.54 The use of DMSO could potentially interfere with 
the photochemical reaction rates. Conventional PDT agents 
requires molecular oxygen to generate singlet oxygen. This 
work shows that blebbistatin photoinactivation occurs without 
need for oxygen (Figures 3c); oxygen levels present a 
technical challenge for PDT delivery within the hypoxic 
tumor microenvironment. This work, on the other hand, 
suggests that blebbistatin should work under even hypoxic or 
anoxic environments, a proposition deserving future 
validation by biologists in the PACT field. It is noteworthy 
that the blue light dependent photo-release of •OH from 
blebbistatin offers significant advantages over •OH generation 
by UV photolysis or Fenton reaction. •OH generation by 
photolysis depends on high energy UV light which invariably 
elicits photodamage and photodecomposition of biological 
molecules in living cells and in vivo samples. Fenton reaction 
requires fresh preparations and the production of •OH is 
highly precipitous and hard to harness in a controlled manner. 
In contrast, photoexcitation of blebbistatin permits control 
over the rate and amount of •OH release via adjusting the 
source of light used (Figure 7S), with blue light being a form 
of irradiation therapeutically superior to UV. The 
fluorescence enhancement of HPF by photoexcitation of 
blebbistatin was also found to be more efficient than that by 
Fenton’s reagent when used at a comparable concentration 
(Figure 3e). 
4. Two-photon excitation (800 nm) of blebbistatin in an 
aqueous solution 
Although blebbistatin can undergo blue light-triggered 
photocleavage to yield its final product in an aqueous solution, 
blue light has relatively small penetration depth, which may 
restrain blebbistatin’s potential for PACT applications. We 
envisage that if the compound can instead be photoexcited by 
a two-photon process with wavelengths above 800 nm, it 
would be very useful for the development of PACT capable of 
reaching tissues of greater depth. Figure 4a shows the UV-vis 
absorption evolution of blebbistatin excited by near infrared 
light (800 nm) with 180 mW laser power. Evidently, 
blebbistatin can efficiently undergo two-photon excitation 
triggered photochemical reaction to produce the final product, 
as observed with one-photon blue light excitation (Figure 3S 
(right)). This strongly suggests that blebbistatin can 
photorelease •OH by two-photon excitation, whose excitation 
wavelength is in near infrared region, which is fairly efficient 
in penetrating living cells and tissues. To explore the two-
photon absorption properties of blebbistatin, the samples were 
measured by an open/closed aperture Z-scan technique, with 
an 800 nm pulsed laser and a repetition rate of 1 kHz. The 
position of the sample cell can be altered along the z-axis (the 
laser-beam direction), while obtaining the transmittance 
changes in the far field. β is the nonlinear absorption 
coefficient. The two-photon absorption coefficient β is 
obtained by fitting the experimental transmittance data. The 
two-photon absorption cross-section (δ) is thus calculated by 
using the equation  δ = hωβ/(2πN0) , where h𝜔/2π is the 
excitation photon energy and N0 is the number of molecules 
per cm3. δ is generally presented in GM (Göpert-Meyer) units, 
where 1 GM = 1×1050 cm4 s/photon. Figure 4b shows the 
open/closed aperture Z-scan results of blebbistatin measured 
by femtosecond laser pulses at 800 nm. The two-photon 
absorption cross-section of blebbistatin was measured to be 
667 GM. This indicates that blebbistatin intrinsically has an 
excellent two-photon absorption property. Overall, our results 
suggest that blebbistatin can be exploited as a photocage with 
two-photon excitation in therapeutically appealing regions 
(especially near infrared) in biological systems. 
 
Figure 4 UV-vis absorption spectra evolution of blebbistatin in 
aqueous solution after two-photon irradiation at 800 nm (a) and 
the open/close aperture Z-scan results of blebbistatin measured 
by femtosecond laser pulses at 800 nm (b).   
5. CASPT2//CASSCF calculations for photochemical 
mechanisms underlying blebbistatin photoinactivation 
Our mass and NMR spectroscopic results (Figure 5S and 6S) 
show that the difference of the relative molecular mass is the 
weight of one oxygen atom (16) between the initial reactant 
and the N1 protonated product. This indicates that N1 
protonation assisted by ESIPT reaction is a required step 
through the introduction of an additional proton from the 
aqueous solvation. Therefore, the nH2O∙H3O+ complex was 
employed to serve as the donor of the ESIPT reaction, which 
can be used to mimic the water solution surrounding it for the 
direct release of •OH in the presence of an appropriate water 
hydrogen bonding network. Computational tests reveal that 
the stabilization energy reaches its maximum (ca. 30 kcal/mol) 
by the introduction of 6 H2O molecules, i.e., 
blebbistatin∙5(H2O)∙H3O+ and remains almost unchanged with 
the participation of more water molecules (see Table 1S). 
Consequently, the CASPT2//CASSCF calculations of 
blebbistatin∙5(H2O)∙H3O+ complex were performed to 
examine the minimum energy profile associated with the 
photochemistry of blebbistatin. This serves to further 
elucidate how the water-assisted ESIPT process drives 
blebbistatin photoinactivation to release •OH and produces the 
inactive final product 1. As shown in Figure 5, upon 
photoexcitation at 419 nm, blebbistatin is instantaneously 
populated in the Frank-Condon region of strongly allowed SCT 
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Figure 5 Shown are the minimum energy profiles based on integration of fs-TA spectroscopic data and CASPT2//CASSCF calculations (a). 
Proposed mechanistic pathway of blebbistatin•5H2O•H3O+ (b). 
(1ππ*) state (f = 0.18) that initiates the charge transfer along a 
desired direction from the tolyl ring to the center 3-
hydroxypyridin-4(3H)-one ring. As a result, a noticeable 
negative charge significantly accumulates around N1 of the 3-
hydroxypyridin-4(3H)-one ring and carbonyl C2=O3 (refer to 
numbered atoms in Figure 5), which facilitates the occurrence 
of the subsequent ESIPT reaction aided by water. Consistently, 
a tiny barrier (TS1, 3.6 kcal/mol) is found in the N1 
protonation pathway of the SCT (
1ππ*) state, producing the first 
intermediate (INT-1). N1 protonation leads to a slight 
decrease in the accumulation of negative charge around the 
proton acceptor carbonyl O3 from 0.68 in the minimum of 
SCT (
1ππ*) state, SCT (1ππ*)-Min, to 0.64 in INT-1. 
Accordingly, a moderate barrier (TS2, 9.1 kcal/mol) is 
determined in the second step of ESIPT reaction, i.e., 
protonation of carbonyl C2=O3 with the concomitant 
deprotonation of hydroxyl O5-H6. 
As shown in Figure 5, although deprotonation of hydroxyl 
O5-H6 is a driving force of the ESIPT reaction, protonation 
of the carbonyl group and N1 is done by the water solvent. 
This finding is also corroborated by the labeling experiments, 
as shown in Figure 1e. With the accomplishment of 
deprotonation of hydroxyl O5H6, a negative charge center is 
bared around O5 which becomes ready for nucleophilic attack 
on carbocation of C2. On the other hand, the released proton 
from the hydroxyl O5H6 simultaneously drives a series of 
proton translocations toward the oxygen of carbonyl C2=O3 
via a water chain, producing the enol form of C2-O3-H. As a 
result, the carbocation ion C2+ is generated through an 
effective charge translocation from C2 to O5 along a water 
wire. Obviously, the formed C2+O5  pair is 
considerably stabilized by the introduced water wire through 
the strong hydrogen bond interactions between the water 
molecules and C2-O3-H, the bare O5 and N1H moieties. 
Meanwhile, the energetic level of ground state gradually 
increases and eventually reaches the conical intersection of CI 
(SCT/S0) between SCT (
1ππ*) and ground state that functions as 
an effective relay to enable a very fast combination of C2+ and 
O5 in the ground state, giving rise to the formation of a short-
lived epoxide-like intermediate INT-2, whose energy is 29.4 
kcal/mol less than that of the CI (SCT/S0). Once the active INT-
2 is formed, the proton H7 backward transfer is immediately 
initiated due to the strong attraction of the O5 that has some 
negative charge. This leads to the instant ring opening of the 
epoxide while the heterolysis of C2O5 is triggered 
simultaneously along a concerted reaction path. In an aqueous 
solution in which the surrounding environment of blebbistatin 
is water, water plays a pivotal role in opening the epoxide-like 
intermediate. This is the main reason why no addition of 
amine (piperidine) to an epoxide compound was observed in 
aqueous solutions. By surmounting an 18.2 kcal/mol barrier, 
an OH anion is finally released with the formation of a cation 
in the conjugation ring moiety along the reaction path of 
C2O5 bond heterolysis. Meanwhile, the energy level for the 
generation of •OH decreases progressively and approaches the 
formation path of OH- anion. The energy gap is narrowed 
eventually to 5.3 kcal/mol between the two channels. This 
indicates that the •OH is likely produced through single 
electron transfer (SET) from the OH anion to the center 
pyridine ring by overcoming a tiny barrier. The present 
computational results demonstrate that photoexcitation of 
blebbistatin leads to coexistence of OH anion and •OH. No 
electron paramagnetic resonance (EPR) signal for •OH was 
detected (Figure 8S), though •OH could nonetheless be 
visualized by the chemoselective fluorescent probes HPF and 
HKOH-1 (Figure 3b and 3f). Intrinsically, fluorescence 
measurement affords superior sensitivity and selectivity, 
thereby enabling •OH detection of extremely low analytic 
levels beyond the detection limit of EPR. 
6. Potentiation of cytotoxicity of blebbistatin by blue light. 
Owing to its unusual photochemical attributes and efficient 
photoconversion in the presence of blue light, blebbistatin is 
anticipated to operate as an oxidant generator in the cellular 
environment. While our chemical validation results do not 
support the in vitro formation of superoxide or singlet oxygen 
(Figure 3a and 3c), which are otherwise well-documented 
ROS formed in photodynamic experiments with UV 
irradiation, the observed atypical •OH formation in an aqueous 
chemical system implies that blebbistatin could 
photochemically behave in similar manners in living cells, 
thereby rapidly modifying cellular components through 
oxidation. We attempted to validate this effect in skin cancer 
cells of two types. In the presence of blue light (refer to 
Methods on conditions for cytotoxicity assay), blebbistatin 
exhibited increased cytotoxicity toward A375 human 
melanoma cells and B16 mouse melanoma cells (Figure 6a).
0 2 4 6 8 10 12 14
0
15
30
45
60

E
 /
 k
ca
l 
m
o
l-
1
Intrinsic Reaction Coordinate / amu
1/2
 · Bohr
 
 SCT(1ππ*)-FC
SCT(
1ππ*)-Min
S0
TS1
INT-1
TS2
CI(SCT/S0)
INT-2
·OH 
hν
419nm
N1
O5
O3
H6
H7
H8
C4
C2
W2
W3
W4
W5
W6
W1
Diradical
OH−
OH anion
SET
SCT(
1ππ*)
S0
a b
Page 8 of 13
ACS Paragon Plus Environment
Journal of the American Chemical Society
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
9 
 
 
Figure 6 Potentiation of cytotoxicity of blebbistatin by blue light. a, Evaluation of cytotoxicity of blebbistatin in the presence or absence of 
blue light (hv) in B16 mouse melanoma cells and A375 human melanoma cells by MTT assay. Results are representative of three independent 
experiments. b, Time-lapse confocal imaging of B16 cells after exposure to blebbistatin and blue light (30 min). Cells were stained with 
propidium iodide (PI) imaging before imaging. Scale bar = 100 µm. c, Quantitation of PI fluorescence intensities in cells treated with 
blebbistatin at 25 µM in b with additional controls. d, Time-lapse confocal imaging of PI-stained B16 cells exposed to varying durations of 
treatment with blebbistatin (25 µM) and blue light. Scale bar = 200 µm. e, Quantitation of fluorescence intensities of cells in d. f, Effects of 
thiourea on cell death induced by blebbistatin and blue light. Cells were first pre-incubated (30 min) with thiourea at indicated concentrations 
and then subjected to challenge of blebbistatin (25 µM) and blue light (30 min). Statistical significance was determined at ***p < 0.001 by 
Student’s t test. 
In MTT assay, blue light irradiation resulted in a reduction 
of >2.6 and >4.1 folds in IC50 values for A375 and B16 cells, 
respectively. It was anticipated that blue light illuminated 
blebbistatin extends its effects by increasing cell permeability. 
Indeed, in time-lapse confocal imaging (Figure 6b), blue light 
illuminated blebbistatin (10 and 25 µM) caused a loss in 
plasma membrane integrity in B16 cells to a degree that 
depends on the dose and time of exposure to light, as assessed 
by propidium iodide (PI) staining. At 25 µM, blue light 
illuminated blebbistatin was most effective and induced a 
maximal increase in cell permeability in B16 cells from 6h 
post-treatment (Figure 6c). To evaluate how efficiently blue 
light induced a loss of the integrity of the plasma membrane 
in blebbistatin-treated cells, B16 cells were exposed to blue 
light for various time durations (5, 15 and 30 min). The results 
suggest that blue light illuminated blebbistatin approached its 
maximal effects by 30 min (Figure 6d). PI staining increased 
by about 8 times upon blue light irradiation, relative to 
baseline of the untreated control (Figure 6e). We anticipated 
that the observed cytotoxicity by blue light illuminated 
blebbistatin can be partially reduced by thiourea, an 
established scavenger for •OH . It has been established that 
thiourea is highly recalcitrant to UV irradiation and does not 
undergo any photochemical reactions.55 We also validated the 
UV absorption spectra of thiourea in acetonitrile (see Figure 
9S), which has an absorption peak squarely in the UV regions 
(< 300 nm), thus precluding any of chance of thiourea to 
undergo photochemical reaction in the visible light regions. 
Because thiourea (in mM range) reacts with a downstream 
photoproduct (•OH ) of the blebbistatin photoinactivation 
process, it is anticipated to act as a sink for •OH (known to 
occur in equilibrium in pM range) without effects on the 
photochemistry of blebbistatin in the chemical system. Indeed, 
in MTT assay, thiourea pretreatment (30 min) significantly 
improved the viability of B16 and C375 cells exposed to blue 
light and blebbistatin (25 µM, 30 min) (Figure 6f). 
7. Flow cytometry analysis of cell death during blue light 
illumination of blebbistatin 
Identifying the types of cell death induced by blue light 
illuminated blebbistatin is of interest, because non-pyrogenic 
cell death such as apoptosis generally elicits minimal local 
inflammation and therefore less adverse effect in therapeutic 
contexts. In order to further clarify the effects of blue light 
illuminated blebbistatin (25 µM) at the cellular level, we 
performed flow cytometry (FACS) analysis in C375 and B16 
cells to elucidate the types of cell, death brought about. As 
shown in Figure 7a, 30 min exposure to blue light illuminated 
blebbistatin (bleb + hv) resulted in a significant increase in PI- 
and Annexin A5 double-positive cells as well as Annexin A5 
mono-positive cells by 4 h posttreatment, indicating increased 
cell death  of late apoptosis and early apoptosis, respectively. 
Consistent with this observation, blue light illuminated 
blebbistatin (25 µM; 30 min) rapidly induced a disappearance 
of mitochondrial membrane activity, an initial part in the    
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Figure 7 Analysis of cell death during blue light illumination of blebbistatin. a, A375 and B16 Cells were challenged with blebbistatin (25 
µM) alone, blue light alone, or blebbistatin and blue light for 30 min, and briefly stained with PI and Annexin A5 for flow cytometry analysis. 
b, Representative confocal images of C375 cells treated with blebbistatin (25 µM) in the presence of absence of blue light (30 min), and 
stained with JC-1 (2.5 µM). Scale bar = 50 µm. (Inset) Quantification of red-to-green fluorescence emission ratios of cells (n ≥ 207) in b. c, 
Effects of blebbistatin (25 µM) and blue light (30 min) on mitochondrial superoxide formation in C375 cells, as visualized by MitoSOX (2 
µM) in confocal imaging. Scale bars = 10 µm. (Inset) Quantification of fluorescence intensities in cells (n ≥ 133) in c. d, Representative 
confocal images of mitochondrial morphology of C375 cells stained with MitoTracker Deep Red (20 nM) with (right) or without (left) 
treatment of blebbistatin (25 µM) and blue light. Scale bar = 5 µM. e, Response of A375 cells and B16 cells to blue light alone, blebbistatin 
alone, or blebbistain (25 µM) and blue light (30 min) in a quantitative assay for caspase-3 activity. f, Response of A375 cells and B16 cells 
to blue light alone, blebbistatin alone, or blebbistain (25 µM) and blue light (30 min) in a quantitative assay for caspase-8 activity. Statistical 
significance was determined at **p < 0.01 and ***p < 0.001 by Student’s t test. 
apoptotic cascade in C375 cells, as assessed by the membrane-
potential sensitive dye JC-1 (2.5 µM) (Figure 7b). 
Mitochondrial superoxide formation another indicator for 
activation of mitochondrial-dependent apoptosis, was 
strongly induced by blue light illuminated blebbistatin (25 µM; 
30 min) in C375 cells as measured by the established 
mitochondrial superoxide probe MitoSOX (2 µM) (Figure 7c). 
In addition, blue light illuminated blebbistatin (25 µM; 30 min) 
treatment also resulted in marked changes in mitochondrial 
morphology in C375 cells, as monitored with MitoTracker 
Deep Red (20 nM). Exposure to blue light and blebbistatin 
rapidly increased fissure of mitochondria, which displayed 
toroidal (donut-like) features suggestive of a stressed state 
instead of tubular morphology characteristic of resting 
mitochondria (Figure 7d). Lastly, quantitative caspase activity 
assays were performed to determine the apoptotic mediators 
involved. The results suggest that in both C375 and B16 cells, 
blue light illuminated blebbistatin (25 µM; 30 min) 
significantly upregulated the action of caspase-3 (Figure 7e) 
and caspase-8 (Figure 7f) by 4 h posttreatment, further 
confirming that blebbistatin potently induced apoptosis in 
melanoma cells in the presence of blue light. Our results 
indicate that blue wavelength photon illumination of 
blebbistatin is a robust approach to rapidly induce 
mitochondria-dependent apoptosis in melanoma cells, which 
presents features reminiscent of cell death induced by other 
PDT agents.56,57 However, the unique photochemical 
characteristic of blebbistatin to directly generate •OH is likely 
to be important to its enhanced cytotoxic effects, which 
distinguishes blebbistatin from conventional PDT agents for 
which singlet oxygen or superoxide are the initial or primary 
ROS. Based on our experimental results, blebbistatin 
therefore operates not as a typical photosensitizer but rather a 
photocage or PACT agent. Our cell imaging studies (e.g. loss 
of mitochondrial membrane potential, mitochondrial 
morphological changes, etc.) suggest that although 
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blebbistatin itself does not release superoxide (Figure 3a), 
directly released •OH from blebbistatin potentially sets off a 
cascade of cell stress events that include the production of 
intracellular ROS (e.g. mitochondrial superoxide, Figure 7c), 
which could perpetuate the cell damage leading the eventual 
cell death observed (Figures 6a and 7a). 
CONCLUSION 
The present study on the photochemical mechanisms 
underlying blue light photoinactivation of blebbistatin has 
revealed an unexpected mode of blebbistatin phototoxicity, in 
which water-assisted ESIPT enables an unprecedented direct 
photo-release of •OH from blebbistatin in aqueous solutions. 
This process bypasses the generation of singlet oxygen or 
superoxide as would be anticipated in conventional PDT. Our 
results suggest that such photo-release of •OH involves 
hydrogen bonding between water molecules and blebbistatin 
via concerted protonation and ESIPT, which allows 
blebbistatin to structurally evolve along a energetically 
favorable pathway on the potential energy landscape to 
release •OH. Efficient blue light photoconversion of 
blebbistatin suggests that this photo-labile compound can be 
exploited as a useful photocage for controlled release of •OH, 
with practical advantage over conventional mode of •OH 
generation such as Fenton reaction. Remarkably, blebbistatin 
is efficiently photocleaved by two-photon photoexcitation as 
evidenced in absorption spectra which means that near 
infrared light can also trigger the cage to photorelease •OH. 
Blebbistatin can therefore act potentially as a useful PACT 
agent in therapy development. To the best of our knowledge, 
there have been no successful attempts in delivering Fenton 
reagents (namely, free iron (II) and H2O2 at 100500 µM) to 
target tissue sites as a therapeutic strategy. Most exogenous 
iron in biological systems are quickly assimilated by iron 
carrier proteins such as ferritin and transferrin as a cellular 
protective response. In addition, conventional PDT agents are 
functionally dependent on molecular oxygen to generate 
singlet oxygen. For drug delivery to deep tissues or hypoxic 
tumor microenvironment, this presents technical challenges 
and limits the efficacy of conventional PDT agents. On the 
other hand, our fs-TA spectroscopic findings on blebbistatin 
clearly demonstrate that photorelease of •OH and blebbistatin 
photoinactivation occur without the need for molecular 
oxygen, which potentially is an advantage distinctive of 
blebbistatin photochemistry. Collectively, our results have 
revealed an underappreciated mechanism by which small-
molecule compounds can be efficiently transformed in 
therapeutically desirable regions of the excitation/emission 
spectra. We find it exciting to speculate that blebbistatin’s 
photochemical attributes can have practical implications in 
PACT for treating refractory conditions such as skin cancers 
and microbial infections. As a blue light-gated photocage for 
•OH generation, blebbistatin can also serve as a conceptual 
blueprint for rational design and development of new PACT 
agents. These will be worthwhile areas for future investigation. 
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